J. HIRSHFIELD

3.2k total citations · 2 hit papers
13 papers, 2.6k citations indexed

About

J. HIRSHFIELD is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, J. HIRSHFIELD has authored 13 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in J. HIRSHFIELD's work include Chemical Synthesis and Analysis (4 papers), Pharmacological Effects of Natural Compounds (2 papers) and Neuropeptides and Animal Physiology (2 papers). J. HIRSHFIELD is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Pharmacological Effects of Natural Compounds (2 papers) and Neuropeptides and Animal Physiology (2 papers). J. HIRSHFIELD collaborates with scholars based in United States. J. HIRSHFIELD's co-authors include Paul Anderson, James P. Springer, Alfred W. Alberts, Kenneth E. Rittle, Mark G. Bock, Roger Freidinger, Robert M. DiPardo, Daniel F. Veber, B. Evans and G. F. Lundell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

J. HIRSHFIELD

13 papers receiving 2.4k citations

Hit Papers

Mevinolin: a highly potent competitive inhibitor of hydro... 1980 2026 1995 2010 1980 1988 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    1980 1.3k citations Alfred W. Alberts, G. W. Kuron et al. Proceedings of the National Academy of Sciences profile →
  2. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
    1988 1.2k citations B. Evans, Kenneth E. Rittle et al. Journal of Medicinal Chemistry profile →

Peers

J. HIRSHFIELD
Jeffrey A. Pfefferkorn United States
Agostino Casapullo Italy
Yoichi Hayakawa Japan
Brad R. Henke United States
Delf Schmidt Germany
Shunji Aoki Japan
Hans C. Rilling United States
Maria Giovanna Chini Italy
Nikos G. Oikonomakos Greece
Nobuharu Shigematsu Japan
Jeffrey A. Pfefferkorn United States
J. HIRSHFIELD
Citations per year, relative to J. HIRSHFIELD J. HIRSHFIELD (= 1×) peers Jeffrey A. Pfefferkorn

Countries citing papers authored by J. HIRSHFIELD

Since Specialization
Citations

This map shows the geographic impact of J. HIRSHFIELD's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. HIRSHFIELD with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. HIRSHFIELD more than expected).

Fields of papers citing papers by J. HIRSHFIELD

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. HIRSHFIELD. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. HIRSHFIELD. The network helps show where J. HIRSHFIELD may publish in the future.

Co-authorship network of co-authors of J. HIRSHFIELD

This figure shows the co-authorship network connecting the top 25 collaborators of J. HIRSHFIELD. A scholar is included among the top collaborators of J. HIRSHFIELD based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. HIRSHFIELD. J. HIRSHFIELD is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Singh, Sheo B., Deborah L. Zink, Anne W. Dombrowski, et al.. (2003). Integracides: tetracyclic triterpenoid inhibitors of HIV-1 integrase produced by Fusarium sp.. Bioorganic & Medicinal Chemistry. 11(7). 1577–1582. 22 indexed citations
2.
Wu, Mingshu, Malcolm MacCoss, Theodore J. Ikeler, et al.. (1990). Annelated piperazinyl‐7,8‐dihydro‐6H‐thiopyrano[3,2‐d]pyrimidines. Journal of Heterocyclic Chemistry. 27(6). 1559–1563. 3 indexed citations
3.
Evans, B., Kenneth E. Rittle, Mark G. Bock, et al.. (1988). Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. Journal of Medicinal Chemistry. 31(12). 2235–2246. 1177 indexed citations breakdown →
4.
Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1988). ChemInform Abstract: Synthesis and Resolution of 3‐Amino‐1,3‐dihydro‐5‐phenyl‐2H‐1,4‐benzodiazepin‐2‐ones.. ChemInform. 19(2). 2 indexed citations
5.
Evans, B., Kenneth E. Rittle, Mark G. Bock, et al.. (1987). ChemInform Abstract: Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists.. ChemInform. 18(50). 3 indexed citations
6.
STOKKER, G. E., Alfred W. Alberts, Paul Anderson, et al.. (1986). 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted-[1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives. Journal of Medicinal Chemistry. 29(2). 170–181. 52 indexed citations
7.
Thorsett, Eugene D., Elbert E. Harris, Susan D. Aster, et al.. (1986). ChemInform Abstract: Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme: Synthesis and Computations.. Chemischer Informationsdienst. 17(23). 9 indexed citations
8.
STOKKER, G. E., et al.. (1986). Synthesis and x-ray characterization of 6(S)-epimevinolin, a lactone epimer. The Journal of Organic Chemistry. 51(25). 4931–4934. 10 indexed citations
9.
Jones, James H., Paul Anderson, John J. Baldwin, et al.. (1985). ChemInform Abstract: SYNTHESIS OF 4‐SUBSTITUTED 2H‐NAPHTH(1,2‐B)‐1,4‐OXAZINES, A NEW CLASS OF DOPAMINE AGONISTS. Chemischer Informationsdienst. 16(23). 4 indexed citations
10.
11.
Springer, James P., et al.. (1981). ChemInform Abstract: THE ABSOLUTE STEREOCHEMISTRY AND CONFORMATION OF AVERMECTIN B2A AGLYCONE AND AVERMECTIN B1A. Chemischer Informationsdienst. 12(43). 5 indexed citations
12.
13.
Alberts, Alfred W., G. W. Kuron, V. M. Hunt, et al.. (1980). Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.. Proceedings of the National Academy of Sciences. 77(7). 3957–3961. 1298 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Pfefferkorn Breakdown of academic impact, for papers by Agostino Casapullo Breakdown of academic impact, for papers by Yoichi Hayakawa Breakdown of academic impact, for papers by Brad R. Henke Breakdown of academic impact, for papers by Delf Schmidt Breakdown of academic impact, for papers by Shunji Aoki Breakdown of academic impact, for papers by Hans C. Rilling Breakdown of academic impact, for papers by Maria Giovanna Chini Breakdown of academic impact, for papers by Nikos G. Oikonomakos Breakdown of academic impact, for papers by Nobuharu Shigematsu
Rankless by CCL
2026